Inspire Advisors LLC cut its position in shares of Innospec Inc. (NASDAQ:IOSP – Free Report) by 4.8% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,491 shares of the specialty chemicals company’s stock after selling 328 shares during the period. Inspire Advisors LLC’s holdings in Innospec were worth $734,000 at the end of the most recent reporting period.
A number of other large investors have also modified their holdings of IOSP. Vanguard Group Inc. boosted its stake in Innospec by 5.5% during the first quarter. Vanguard Group Inc. now owns 3,115,167 shares of the specialty chemicals company’s stock worth $401,670,000 after buying an additional 161,249 shares in the last quarter. Wasatch Advisors LP increased its stake in Innospec by 1.1% in the first quarter. Wasatch Advisors LP now owns 1,972,110 shares of the specialty chemicals company’s stock valued at $254,284,000 after acquiring an additional 22,094 shares during the period. Bank of New York Mellon Corp raised its position in Innospec by 2.4% in the second quarter. Bank of New York Mellon Corp now owns 258,294 shares of the specialty chemicals company’s stock worth $31,923,000 after purchasing an additional 6,148 shares in the last quarter. Sei Investments Co. lifted its stake in Innospec by 4.9% during the first quarter. Sei Investments Co. now owns 138,788 shares of the specialty chemicals company’s stock worth $17,895,000 after purchasing an additional 6,532 shares during the period. Finally, Bessemer Group Inc. boosted its holdings in Innospec by 3.2% during the first quarter. Bessemer Group Inc. now owns 121,921 shares of the specialty chemicals company’s stock valued at $15,720,000 after purchasing an additional 3,775 shares in the last quarter. 96.64% of the stock is currently owned by institutional investors and hedge funds.
Innospec Price Performance
Innospec stock opened at $113.31 on Friday. Innospec Inc. has a 52-week low of $95.69 and a 52-week high of $133.71. The stock has a fifty day moving average price of $111.26 and a two-hundred day moving average price of $119.99. The firm has a market capitalization of $2.83 billion, a P/E ratio of 18.98 and a beta of 1.07.
Analyst Ratings Changes
Separately, StockNews.com cut Innospec from a “strong-buy” rating to a “buy” rating in a report on Thursday, August 8th.
Get Our Latest Stock Analysis on Innospec
Insider Activity
In related news, CFO Ian Cleminson sold 3,398 shares of the stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $114.74, for a total transaction of $389,886.52. Following the sale, the chief financial officer now directly owns 12,996 shares in the company, valued at $1,491,161.04. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.35% of the stock is currently owned by corporate insiders.
Innospec Profile
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
See Also
- Five stocks we like better than Innospec
- When to Sell a Stock for Profit or Loss
- Survey Reveals: America’s Most Coveted Businesses in 2024
- What is the S&P 500 and How It is Distinct from Other Indexes
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- What Are Dividend Challengers?
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.